Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 10
2021 37
2022 27
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Introducing Immunotherapy Advances.
Elliott T. Elliott T. Immunother Adv. 2020 Nov 25;1(1):ltaa009. doi: 10.1093/immadv/ltaa009. eCollection 2021 Jan. Immunother Adv. 2020. PMID: 36284897 Free PMC article. No abstract available.
Immunology of allergen immunotherapy.
Rahman RS, Wesemann DR. Rahman RS, et al. Immunother Adv. 2022 Nov 25;2(1):ltac022. doi: 10.1093/immadv/ltac022. eCollection 2022. Immunother Adv. 2022. PMID: 36530352 Free PMC article. Review.
Immunotherapy advances: One year on.
Elliott T. Elliott T. Immunother Adv. 2022 Jan 11;2(1):ltac001. doi: 10.1093/immadv/ltac001. eCollection 2022. Immunother Adv. 2022. PMID: 35919492 Free PMC article. No abstract available.
Correction.
[No authors listed] [No authors listed] Immunother Adv. 2022 Aug 11;2(1):ltac018. doi: 10.1093/immadv/ltac018. eCollection 2022. Immunother Adv. 2022. PMID: 35967910 Free PMC article.
Oral tolerance as antigen-specific immunotherapy.
Pinheiro-Rosa N, Torres L, Oliveira MA, Andrade-Oliveira MF, Guimarães MAF, Coelho MM, Alves JL, Maioli TU, Faria AMC. Pinheiro-Rosa N, et al. Immunother Adv. 2021 Aug 25;1(1):ltab017. doi: 10.1093/immadv/ltab017. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919733 Free PMC article. Review.
MicroRNAs: immune modulators in cancer immunotherapy.
Xing Y, Wang Z, Lu Z, Xia J, Xie Z, Jiao M, Liu R, Chu Y. Xing Y, et al. Immunother Adv. 2021 May 13;1(1):ltab006. doi: 10.1093/immadv/ltab006. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919742 Free PMC article. Review.
Targeting immunometabolism to treat COVID-19.
O'Carroll SM, O'Neill LAJ. O'Carroll SM, et al. Immunother Adv. 2021 Jun 2;1(1):ltab013. doi: 10.1093/immadv/ltab013. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 34240083 Free PMC article. Review.
A summary of current NKG2D-based CAR clinical trials.
Curio S, Jonsson G, Marinović S. Curio S, et al. Immunother Adv. 2021 Aug 13;1(1):ltab018. doi: 10.1093/immadv/ltab018. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 34604863 Free PMC article. Review.
Special Review: The future of Immunotherapy.
Melief CJM. Melief CJM. Immunother Adv. 2020 Nov 25;1(1):ltaa005. doi: 10.1093/immadv/ltaa005. eCollection 2021 Jan. Immunother Adv. 2020. PMID: 36756002 Free PMC article. Review.
60 results